BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 26598427)

  • 1. Determinants of Prostate Specific Antigen Screening among Black Men in the United States in the Contemporary Era.
    Sammon JD; Dalela D; Abdollah F; Choueiri TK; Han PK; Hansen M; Nguyen PL; Sood A; Menon M; Trinh QD
    J Urol; 2016 Apr; 195(4 Pt 1):913-8. PubMed ID: 26598427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial Disparities in Prostate Specific Antigen Screening and Referral to Urology in a Large, Integrated Health Care System: A Retrospective Cohort Study.
    Lu CD; Adeyemi O; Anderson WE; Hetherington TC; Slawson DC; Tapp H; Eaton TA; Burgess EF; Grigg CM; Zhu JZ; Gaston KE; Riggs SB; Clark PE; Taylor YJ; Kearns JT
    J Urol; 2021 Aug; 206(2):270-278. PubMed ID: 33793294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demographic, Social Support, and Community Differences in Predictors of African-American and White Men Receiving Prostate Cancer Screening in the United States.
    Dickey SL; Cormier EM; Whyte J; Graven L; Ralston PA
    Public Health Nurs; 2016 Nov; 33(6):483-492. PubMed ID: 26790837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abrogation of survival disparity between Black and White individuals after the USPSTF's 2012 prostate-specific antigen-based prostate cancer screening recommendation.
    Kim IE; Jang TL; Kim S; Modi PK; Singer EA; Elsamra SE; Kim IY
    Cancer; 2020 Dec; 126(23):5114-5123. PubMed ID: 32888321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Relationship Between Education and Prostate-Specific Antigen Testing Among Urban African American Medicare Beneficiaries.
    Hararah MK; Pollack CE; Garza MA; Yeh HC; Markakis D; Phelan-Emrick DF; Wenzel J; Shapiro GR; Bone L; Johnson L; Ford JG
    J Racial Ethn Health Disparities; 2015 Jun; 2(2):176-83. PubMed ID: 26863336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial Disparities in Prostate Cancer Screening: The Role of Shared Decision Making.
    Frego N; Beatrici E; Labban M; Stone BV; Filipas DK; Koelker M; Lughezzani G; Buffi NM; Osman NY; Lipsitz SR; Sammon JD; Kibel AS; Trinh QD; Cole AP
    Am J Prev Med; 2024 Jan; 66(1):27-36. PubMed ID: 37567369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparities Associated with Shared Decision-making in Prostate Cancer Screening.
    Basin MF; Crane K; Basnet A; Chandrasekar T; Shapiro O; Jacob JM; Bratslavsky G; Goldberg H
    Eur Urol Focus; 2023 Nov; 9(6):1008-1015. PubMed ID: 37198068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans?
    Hudson MA; Luo S; Chrusciel T; Yan Y; Grubb RL; Carson K; Scherrer JF
    Urol Oncol; 2014 Jan; 32(1):34.e9-18. PubMed ID: 23506962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Relationship of Baseline Prostate Specific Antigen and Risk of Future Prostate Cancer and Its Variance by Race.
    Verges DP; Dani H; Sterling WA; Weedon J; Atallah W; Mehta K; Schreiber D; Weiss JP; Karanikolas NT
    J Natl Med Assoc; 2017 Spring; 109(1):49-54. PubMed ID: 28259216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
    Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
    JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician Consultations, Prostate Cancer Knowledge, and PSA Screening of African American Men in the Era of Shared Decision-Making.
    Woods-Burnham L; Stiel L; Wilson C; Montgomery S; Durán AM; Ruckle HR; Thompson RA; De León M; Casiano CA
    Am J Mens Health; 2018 Jul; 12(4):751-759. PubMed ID: 29658371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate Cancer Screening in Early Medicaid Expansion States.
    Sammon JD; Serrell EC; Karabon P; Leow JJ; Abdollah F; Weissman JS; Han PKJ; Hansen M; Menon M; Trinh QD
    J Urol; 2018 Jan; 199(1):81-88. PubMed ID: 28765069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
    Lediju O; Ikuemonisan J; Salami SS; Adejoro O
    J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Veteran Status Mitigate Racial Disparities in Prostate Cancer Screening? Analysis of Prostate Specific Antigen Screening Patterns in the 2018 Behavioral Risk Factor Surveillance System Data.
    Alkhatib K; Labban M; Briggs L; Nguyen DD; Herzog P; Cole AP; Haag A; Trinh QD
    J Urol; 2022 May; 207(5):993-1000. PubMed ID: 34967663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do Black NonHispanic Men Produce Less Prostate Specific Antigen in Benign Prostate Tissue or Cancer Compared to White NonHispanic Men with Gleason Score 6 (Grade Group 1) Prostate Cancer?
    Kryvenko ON; Epstein JI; Cote RJ
    J Urol; 2016 Dec; 196(6):1659-1663. PubMed ID: 27343801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient perspectives of prostate cancer screening vary by race following 2018 guideline changes.
    Riviere P; Kalavacherla S; Banegas MP; Javier-Desloges J; Martinez ME; Garraway IP; Murphy JD; Rose BS
    Cancer; 2023 Jan; 129(1):82-88. PubMed ID: 36345568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient and Physician Factors Associated with Undisclosed Prostate Cancer Screening in a Sample of Predominantly Immigrant Black Men.
    Lepore SJ; Nair RG; Davis SN; Wolf RL; Basch CE; Thomas N; Shmukler C; Ullman R
    J Immigr Minor Health; 2017 Dec; 19(6):1343-1350. PubMed ID: 27449217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Race/ethnicity, risk perception, and receipt of prostate-specific antigen testing.
    Shavers VL; Underwood W; Moser RP
    J Natl Med Assoc; 2009 Jul; 101(7):698-704. PubMed ID: 19634591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probability of an abnormal screening prostate-specific antigen result based on age, race, and prostate-specific antigen threshold.
    Espaldon R; Kirby KA; Fung KZ; Hoffman RM; Powell AA; Freedland SJ; Walter LC
    Urology; 2014 Mar; 83(3):599-605. PubMed ID: 24439009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991-1998.
    Etzioni R; Berry KM; Legler JM; Shaw P
    Urology; 2002 Feb; 59(2):251-5. PubMed ID: 11834397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.